About Bolder Science

Our mission is to provide healthcare professionals with unbiased clinical research information, easily.

Currently, you can access the following clinical trials being conducted worldwide:

359,057 studies
in
219 countries
Clinical trial information and results are updated daily from ClinicalTrials.gov. The latest data update was conducted on 01/15/2021.
This website is for US healthcare professionals

Log In to Bolder Science

or

Don't have an account? Sign Up

Please enter your email address.

You will receive a link to create a new password via email.

Log In

Create an Account

or
(optional) ?

Welcome, !

Please complete the following 4 questions to ensure you receive the information that best suits your needs.

Clinical Trials of Interest

When I’m looking for information on clinical trials, I usually am interested in...

finding clinical trials in which to enroll my patients

Rarely Often

finding newly launched clinical trials (for all phases)

Rarely Often

updates on status changes for clinical trials

Rarely Often

pipeline molecules

Rarely Often

Drug Interventions

Enter up to 3 drug interventions you are currently interested in:

Clinical trial information and results are updated daily from ClinicalTrials.gov. The latest data update was conducted on 01/15/2021.

A Mobile Application to Increase Physical Activity

Clinicaltrials.gov identifier NCT03925363

Recruitment Status Not yet recruiting

First Posted April 24, 2019

Last update posted July 2, 2019

Study Description

Brief summary:

A mobile application will be tested in elderly men and women that is randomized to an application (blind-app) that registers physical activity or an application (feedback-app) where participants in addition set goals for physical activity and gets feedback from the application when these goals are achieved. Participants are randomized in permuted blocks of 10 to the blind-app or feedback-app. The primary outcome is increased physical activity. Secondary outcomes include, cardiovascular disease, diabetes, death, dementia, cancer, falls and fractures.

  • Condition or Disease:Physical Activity
  • Intervention/Treatment: Device: Physical activity mobile-application
  • Phase: N/A
Detailed Description

In this randomized controlled study, it will be tested if a mobile application can increase physical activity and reduce the risk of later non-communicable disease. Participants include individuals that previously have been included in a health survey (Healthy aging initiative, NCT03312439), with a low registered physical activity. Low physical is defined according to WHOs definition, i.e. at least 150 minutes of physical activity per week. Individuals will diabetes will be investigated separately. Individuals will be excluded that cannot walk for exercise, or if they have diseases that severely affects the ability to exercise. We will also seek participants from the general population to be included with only two inclusion criteria; having a smart phone and at least 18 years of age. Participants the meet the inclusion criteria will be randomized to an application that only registers physical activity (blind-app) or an application where the participants will set appropriate goals for physical activity and get proper feedback from the app when these goals are reached (feedback-app). Both groups will have individualized information about proper physical activity. Randomization will be made using sealed envelopes in permuted blocks of 10. Randomization will be stratified on year of birth and sex. The primary outcome will be increased physical activity after 6 months. Secondary outcomes include cardiovascular disease, death, dementia, falls and fractures, diabetes, and improved glucose control in those that already have diabetes. Secondary outcomes also include changes in cardiovascular risk factors, such as blood pressure, blood lipids and obesity. Interaction analysis will be performed to investigate if the effects are different in men and women, based on baseline physical activity and based on age. Based on the results from the previous health survey the individuals have participated in, a power analyses has been conducted. The participants physical activity were registered using accelerometers. The mean steps taken per week was 48000 with a standard deviation of 22000 steps. With assumption that the feedback-app will increase physical activity by at least 15%, 164 individuals would be needed in each group with an alpha level of 0.05 and a power of 80%. For secondary outcome of cardiovascular disease or death, estimates were based on incidence of these outcomes in 3617 individuals that participated in the health survey. During a mean follow up time of 928 days, 221 participants was diagnosed with cardiovascular disease or died during follow up, and 128 were diagnosed with cardiovascular disease. If assuming that the mobil-application will result in 15% lower risk of these two outcomes in those randomized to the feedback-app, 597 and 1371 individuals would be needed in each group, respectively, with the same follow up time. The effects during follow up will be monitored each year of follow up through patient registers. Follow up time is scheduled to a maximum of 2 years. We estimate that we then would need 895 and 2156 individuals in each group due to the shorter follow up time compared to in the example above.

Study Design
  • Study Type: Interventional
  • Estimated Enrollment: 4000 participants
  • Allocation: Randomized
  • Intervention Model: Parallel Assignment
  • Intervention Model Description: Participants will be randomized 1:1 to the feedback-app or the blind-app
  • Masking: Triple (Care Provider, Investigator, Outcomes Assessor)
  • Primary Purpose: Prevention
  • Official Title: A Mobile Application to Increase Physical Activity, a Randomized Controlled Study
  • Estimated Study Start Date: August 2019
  • Estimated Primary Completion Date: January 2021
  • Estimated Study Completion Date: January 2023
Arms and interventions
Arm Intervention/treatment
Active Comparator: Active
Participants will be given a mobile-app where they will get feedback from the device based on their physical activity (feedback app)
Device: Physical activity mobile-application
The active group will be given the feedback app and the control group the blind app
Sham Comparator: Control
Participants will be given a mobile-app that does not give feedback back, but the app will register physical activity (blind app).
Device: Physical activity mobile-application
The active group will be given the feedback app and the control group the blind app
Outcome Measures
  • Primary Outcome Measures: 1. Increased physical activity as measured by the mobile application in steps per day [ Time Frame: 3 years (anticipated) ]
    Increased physical activity in steps per day during the intervention period.
  • Secondary Outcome Measures: 1. Incidence of myocardial infarction [ Time Frame: 3 years ]
    Diagnoses of myocardial infarction will be tracked using national registers.
  • 2. Incidence of diagnosed diabetes [ Time Frame: 3 years ]
    Diabetes diagnoses or start of treatment for diabetes will be tracked using national registers.
  • 3. Incidence of diagnosed fractures [ Time Frame: 3 years ]
    Diagnosed fractures will be tracked using national registers.
  • 4. Incidence of diagnosed dementia [ Time Frame: 3 years ]
    Diagnosed dementia or start of treatment using dementia drugs will be tracked using national registers.
  • 5. Number of participants with high blood pressure [ Time Frame: 1 year (anticipated) ]
    Systolic and diastolic blood pressure will be assessed at baseline and later using a sphygmomanometer.
  • 6. Number of participants with high blood lipids [ Time Frame: 1 year (anticipated) ]
    Blood lipids (cholesterol, LDL-cholesterol, and triglycerides) will be analyzed at baseline and after 6 and 12 months at the department of chemistry.
  • 7. Number of participants with high blood glucose [ Time Frame: 1 year (anticipated) ]
    Blood glucose will be analysed at the departement of clinical chemistry at baseline and follow up.
  • 8. Grade of obesity [ Time Frame: 1 year (anticipated) ]
    Obesity will be assessed using a non-elastic measurement tape at the waist
  • 9. Body weight [ Time Frame: 1 year (anticipated) ]
    Body weight in kilogram measured by a digital scale.
  • 10. Incidence of stroke [ Time Frame: 3 years ]
    Diagnoses of stroke will be tracked using national registers.
  • 11. Incidence of angina pectoris [ Time Frame: 3 years ]
    Diagnoses of angina pectoris will be tracked using national registers.
  • 12. Incident mortality [ Time Frame: 3 years ]
    Death during follow up will be tracked using national registers.
  • 13. Number of participants with high glycated hemoglobin [ Time Frame: 1 year (anticipated) ]
    Glycated hemoglobin will be measured at baseline and follow up at the Department of clinical chemistry
Eligibility Criteria
  • Ages Eligible for Study: 70 to 75 Years (Older Adult)
  • Sexes Eligible for Study: All
  • Accepts Healthy Volunteers: No
Criteria

Inclusion Criteria:

- Previous participants in healthy aging initiative.

Exclusion Criteria:

- Not able to walk or previous medical diagnoses that severely limits the possibility to
exercise.

Contacts and Locations
Contacts
Locations
Sponsors and Collaborators

Västerbotten County Council

Umeå University

More Information
  • Responsible Party: Västerbotten County Council
  • ClinicalTrials.gov Identifier: NCT03925363 History of Changes
  • Other Study ID Numbers: VCC_LIFE-5
  • First Posted: April 24, 2019 Key Record Dates
  • Last Update Posted: July 2, 2019
  • Last Verified: June 2019
  • Individual Participant
    Data (IPD) Sharing
    Statement:
  • Plan to Share IPD: No
  • Studies a U.S. FDA-regulated Drug Product: No
  • Studies a U.S. FDA-regulated Device Product: No